NO20030115D0 - Kontrastmiddel - Google Patents

Kontrastmiddel

Info

Publication number
NO20030115D0
NO20030115D0 NO20030115A NO20030115A NO20030115D0 NO 20030115 D0 NO20030115 D0 NO 20030115D0 NO 20030115 A NO20030115 A NO 20030115A NO 20030115 A NO20030115 A NO 20030115A NO 20030115 D0 NO20030115 D0 NO 20030115D0
Authority
NO
Norway
Prior art keywords
imaging agents
formula
moiety
angiotensin
affinity
Prior art date
Application number
NO20030115A
Other languages
English (en)
Norwegian (no)
Inventor
Magne Solbakken
Original Assignee
Amersham Health As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amersham Health As filed Critical Amersham Health As
Priority to NO20030115A priority Critical patent/NO20030115D0/no
Publication of NO20030115D0 publication Critical patent/NO20030115D0/no
Priority to AT04701136T priority patent/ATE425770T1/de
Priority to US10/541,949 priority patent/US7919071B2/en
Priority to CNA2004800019549A priority patent/CN1723043A/zh
Priority to PCT/NO2004/000002 priority patent/WO2004062568A2/en
Priority to JP2006500737A priority patent/JP2006517539A/ja
Priority to DE602004020049T priority patent/DE602004020049D1/de
Priority to EP04701136A priority patent/EP1581262B1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0819Tripeptides with the first amino acid being acidic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/0002General or multifunctional contrast agents, e.g. chelated agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/0497Organic compounds conjugates with a carrier being an organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Light Receiving Elements (AREA)
NO20030115A 2003-01-09 2003-01-09 Kontrastmiddel NO20030115D0 (no)

Priority Applications (8)

Application Number Priority Date Filing Date Title
NO20030115A NO20030115D0 (no) 2003-01-09 2003-01-09 Kontrastmiddel
AT04701136T ATE425770T1 (de) 2003-01-09 2004-01-09 Kontrastmittel
US10/541,949 US7919071B2 (en) 2003-01-09 2004-01-09 Contrast agent
CNA2004800019549A CN1723043A (zh) 2003-01-09 2004-01-09 造影剂
PCT/NO2004/000002 WO2004062568A2 (en) 2003-01-09 2004-01-09 Conjugate of losartan, valsartan, candesartan or eprosartan and a chelant as contrast agent
JP2006500737A JP2006517539A (ja) 2003-01-09 2004-01-09 造影剤
DE602004020049T DE602004020049D1 (de) 2003-01-09 2004-01-09 Kontrastmittel
EP04701136A EP1581262B1 (de) 2003-01-09 2004-01-09 Kontrastmittel

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO20030115A NO20030115D0 (no) 2003-01-09 2003-01-09 Kontrastmiddel

Publications (1)

Publication Number Publication Date
NO20030115D0 true NO20030115D0 (no) 2003-01-09

Family

ID=19914362

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030115A NO20030115D0 (no) 2003-01-09 2003-01-09 Kontrastmiddel

Country Status (8)

Country Link
US (1) US7919071B2 (de)
EP (1) EP1581262B1 (de)
JP (1) JP2006517539A (de)
CN (1) CN1723043A (de)
AT (1) ATE425770T1 (de)
DE (1) DE602004020049D1 (de)
NO (1) NO20030115D0 (de)
WO (1) WO2004062568A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO20034350D0 (no) * 2003-09-29 2003-09-29 Amersham Health As Optisk avbilding av kolorektal kreft
JP2007512321A (ja) * 2003-11-24 2007-05-17 ジーイー・ヘルスケア・アクスイェ・セルスカプ 造影剤
ATE447417T1 (de) * 2004-03-04 2009-11-15 Ge Healthcare As Konjugate von angiotensin-peptid analoga und chelatbildner für diagnose und therapie
FR2902428B1 (fr) * 2006-06-15 2008-08-15 Servier Lab Nouveaux derives diazeniumdiolates, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CN101536563A (zh) * 2006-11-13 2009-09-16 Lm爱立信电话有限公司 无线电信系统
WO2008072973A2 (en) * 2006-12-11 2008-06-19 Ge Healthcare As Radiolabelled peptide based compounds and uses thereof
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201215388A (en) * 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
GB201103696D0 (en) 2011-03-04 2011-04-20 Ge Healthcare Ltd Technetium labelled peptides
GB201314936D0 (en) 2013-08-21 2013-10-02 Ge Healthcare Ltd Radiolabelling method
GB201322456D0 (en) 2013-12-18 2014-02-05 Ge Healthcare Ltd Radiotracer compositions and methods
WO2019134765A1 (en) 2018-01-08 2019-07-11 Julius-Maximilians-Universitaet Wuerzburg Sartan analogue

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0365378A (ja) * 1989-08-04 1991-03-20 Tokyo Tatsuno Co Ltd 複写伝票
US5808091A (en) * 1991-10-29 1998-09-15 Bracco International B.V. Rhenium and technetium complexes containing a hypoxia localizing moiety
JPH09165378A (ja) 1995-12-15 1997-06-24 Seitai Kinou Kenkyusho:Kk N1−[18f]フルオロベンジル複素環化合物およびそれらの製造法
ATE314097T1 (de) * 1996-10-28 2006-01-15 Amersham Health As Kontrastmittel
CA2405469C (en) 2000-04-12 2012-03-20 Amersham Health As Integrin binding peptide derivatives
WO2001092283A2 (en) 2000-05-31 2001-12-06 Mayo Foundation For Medical Education And Research Cobalamin compounds useful as cardiovascular agents and as imaging agents
GB0031592D0 (en) * 2000-12-28 2001-02-07 Nycomed Amersham Plc Stabilised radiopharmaceutical compositions
GB0105224D0 (en) 2001-03-02 2001-04-18 Nycomed Amersham Plc Improved peptide-chelate conjugates
GB0116815D0 (en) * 2001-07-10 2001-08-29 Nycomed Amersham Plc Improved chelator conjugates
BRPI0210886B8 (pt) * 2001-07-10 2021-05-25 Amersham Health As composto, composição farmacêutica, uso de um composto, e, métodos de geração de imagens, de monitoração do efeito do tratamento de um corpo humano ou animal com uma droga para combater uma condição associada com câncer e de tratamento de câncer ou de uma doença relacionada em um corpo humano ou animal

Also Published As

Publication number Publication date
WO2004062568A2 (en) 2004-07-29
US20070020176A1 (en) 2007-01-25
JP2006517539A (ja) 2006-07-27
US7919071B2 (en) 2011-04-05
EP1581262A2 (de) 2005-10-05
CN1723043A (zh) 2006-01-18
EP1581262B1 (de) 2009-03-18
DE602004020049D1 (de) 2009-04-30
WO2004062568A3 (en) 2004-09-30
ATE425770T1 (de) 2009-04-15

Similar Documents

Publication Publication Date Title
MXPA04000173A (es) Compuestos basados en peptidos.
NO20073039L (no) Kontrastmidler
ATE425770T1 (de) Kontrastmittel
DK1272507T3 (da) Integrinbindende peptidderivater
ATE439868T1 (de) Targetingmittel für molekulare bilderzeugung
ATE314097T1 (de) Kontrastmittel
IL173029A0 (en) Imaging agents
WO1998018497A3 (en) Contrast agents
DE602005024279D1 (de) 5-substituierte-2-phenylaminobenzamide als mek-inhibitoren
WO2005079391A3 (en) Contrast agents for myocardial perfusion imaging
WO2003104425A3 (en) NEW STABLE ANTI-CD22 ANTIBODIES
TR200101673A2 (tr) Düz kas hücrelerinin sıkışmasıyla ilgili hastalıkların tedavisindeki kompozisyonlar için biyokimyasal maddeler.
SG152254A1 (en) Contrast agents for myocardial perfusion imaging
ATE384519T1 (de) Hemmer-darstellende mittel
ATE376428T1 (de) Metallkomplexverbindungen
ATE449847T1 (de) Hepatitis c rezeptorprotein cd81
ATE310736T1 (de) Verbindungen zur bilddarstellung der alzheimer- krankenheit
ATE480552T1 (de) Stq-peptide
WO2005049095A3 (en) Contrast agent imaging angiotensin ii receptors
CY1106950T1 (el) Μονοενυδρο αλας νατριου της s-tενατοπραζολης και εφαρμογη υπο τυπον αναστολεα αντλιας πρωτονιων
WO2007064661A3 (en) Bifunctional metal chelating conjugates
EP1573055A4 (de) Genetische depressionsdiagnose
DK1485090T3 (da) Kombinationer omfattende et epothilonderivat og en imidazotetrazinon
HN2002000112A (es) Sal citrato de 5, 8,14 - triazatetraciclo [10.3.1.02.11.04.9] - hexadeca - 2 (11),3,5,7,9 - pentaeno y composiciones farmaceuticas de la misma.
TW200628170A (en) Contrast agents for myocardial perfusion imaging